Additional file 1: of Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

Supplementary material. Additional supplementary data tables and figures referred to in the manuscript. (PDF 1062 kb)